BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3087659)

  • 1. Simultaneous liquid-chromatographic determination of five antiarrhythmic drugs and their major active metabolites in serum.
    Proelss HF; Townsend TB
    Clin Chem; 1986 Jul; 32(7):1311-7. PubMed ID: 3087659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid-chromatographic determination of antidysrhythmic drugs: procainamide, lidocaine, quinidine, disopyramide, and propranolol.
    Kabra PM; Chen SH; Marton LJ
    Ther Drug Monit; 1981; 3(1):91-101. PubMed ID: 7233493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous liquid-chromatographic determination of three antiarrhythmic drugs: disopyramide, lidocaine, and quinidine.
    Flood JG; Bowers GN; McComb RB
    Clin Chem; 1980 Feb; 26(2):197-200. PubMed ID: 6986211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High performance liquid chromatographic analysis of the antiarrhythmic drugs procainamide, disopyramide, quinidine, propranolol and metabolites from serum extracts.
    Wesley JF; Lasky FD
    Clin Biochem; 1981 Jun; 14(3):113-8. PubMed ID: 6170476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring disopyramide, lidocaine, and quinidine by micellar liquid chromatography.
    Ochoa-Aranda E; Esteve-Romero J; Rambla-Alegre M; Martinavarro-Domínguez A; Bose D
    J AOAC Int; 2011; 94(2):537-42. PubMed ID: 21563688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography in the monitoring of plasma levels of antiarrhythmic drugs.
    Lagerström PO; Persson BA
    J Chromatogr; 1978 Feb; 149():331-40. PubMed ID: 649734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high performance liquid chromatographic assay for tocainide with alternate application for the determination of lidocaine, procainamide, and N-acetylprocainamide.
    Annesley T; Matz K; Davenport R; Giacherio D
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):173-81. PubMed ID: 2421377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of lidocaine, mexiletine, disopyramide, and quinidine in plasma by high performance liquid chromatography.
    Dusci LJ; Hackett LP
    J Anal Toxicol; 1985; 9(2):67-70. PubMed ID: 3990250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic determination of 12 antiarrhythmic drugs in plasma using solid-phase column extraction.
    Verbesselt R; Tjandramaga TB; De Schepper PJ
    Ther Drug Monit; 1991 Mar; 13(2):157-65. PubMed ID: 2053124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of antiarrhythmic drug plasma concentration monitoring.
    Follath F; Ganzinger U; Schuetz E
    Clin Pharmacokinet; 1983; 8(1):63-82. PubMed ID: 6404580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How useful are serum levels of cardiac drugs?
    Pennock RS
    Am Fam Physician; 1978 Apr; 17(4):194-6. PubMed ID: 645538
    [No Abstract]   [Full Text] [Related]  

  • 12. Pre-column derivatization with fluorescamine and high-performance liquid chromatographic analysis of drugs. Application to tocainide.
    Sedman AJ; Gal J
    J Chromatogr; 1982 Nov; 232(2):315-26. PubMed ID: 6818239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of free and total tocainide by high performance liquid chromatography (HPLC) with ultraviolet (UV) detection.
    Harris SC; Guerra C; Wallace JE
    J Forensic Sci; 1989 Jul; 34(4):912-7. PubMed ID: 2503585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of tocainide in serum by capillary gas chromatography.
    Smith PJ
    Ther Drug Monit; 1986; 8(3):361-4. PubMed ID: 3092408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of plasma concentrations of anti-arrhythmia agents].
    Flouvat B
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():47-55. PubMed ID: 6803701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic drug monitoring.
    Howanitz JH; Howanitz PJ
    Clin Lab Med; 1981 Sep; 1(3):501-22. PubMed ID: 6179688
    [No Abstract]   [Full Text] [Related]  

  • 17. Simultaneous analysis of antiarrhythmic drugs and metabolites by high performance liquid chromatography: interference studies and comparisons with other methods.
    Wesley JF; Lasky FD
    Clin Biochem; 1982 Dec; 15(6):284-90. PubMed ID: 6762929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An HPLC method for the simultaneous quantitation of quinidine, procainamide, N-acetylprocainamide, and disopyramide.
    Bridges RR; Jennison TA
    J Anal Toxicol; 1983; 7(2):65-8. PubMed ID: 6190040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous analysis of disopyramide and quinidine in plasma by high-performance liquid chromatography.
    Ahokas JT; Davies C; Ravenscroft PJ
    J Chromatogr; 1980 Jul; 183(1):65-71. PubMed ID: 7400265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring of antiarrhythmic agents.
    Brown JE; Shand DG
    Clin Pharmacokinet; 1982; 7(2):125-48. PubMed ID: 7039925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.